Cambridge Healthtech Institute’s Fifth Annual
Rapid Methods to Assess Quality & Stability of Biologics:
Improving Prediction and Screening
Part of CHI's Ninth Annual The Bioprocessing Summit

August 21-22, 2017 | Westin Copley Place | Boston, MA

Assurance of quality and stability of biologic formulations over the course of intended usage is critical in developing safe and efficacious biopharmaceutical products. Increasing regulatory expectations and aggressive development timelines calls for rapid methodologies to predict and assess the quality and stability of biologics. The fifth annual Rapid Methods to Assess Quality & Stability of Biologics conference will bring together experts in analytical and formulation development to discuss regulatory expectations, prediction and manipulation for protein stability and instabilities caused by particles, higher order structures and impurities. We are seeking case studies and strategies, especially unpublished and innovative work on methods employed in real time and accelerated stability studies, protein aggregates and effective use of DoE for assessment and data comparability from early to late stage development.

Preliminary Agenda

KEYNOTE PRESENTATION: Talk Title to be Announced

Yatin Gokarn, Ph.D., Head, Global Pharmaceutical Development Biologics, Sanofi Genzyme


Critical Considerations in the Characterization of Protein Higher Order Structure (HOS) and Its Relationship with Stability and Function

Haripada Maity, Ph.D., Research Advisor, Formulation Development, CMC Development, Eli Lilly and Company

Application of Spectral Similarity Analysis for Product Comparability Exercises

Thomas F. Lerch, Ph.D., Principal Scientist, BioTherapeutics Pharmaceutical Sciences, Pfizer, Inc.

Using Endoglycosidase and High Resolution Mass Spectrometry to Estimate the Level of MAN-5 and Afucosylation in Monoclonal Antibodies

Ming-Ching Hsieh, Ph.D., Research Advisor, BioAnalytical Science, Eli Lilly and Company


How Well Can We Predict Protein-Protein Interactions and Aggregation Propensity Using Molecular Models during Candidate and Formulation Assessment?

Christopher J. Roberts, Ph.D., Professor, Chemical & Biomolecular Engineering, University of Delaware

Understanding & Verifying Flow Imaging Particle Counters

Dean Ripple, Ph.D., Leader, Bioprocess Measurements Group, National Institute of Standards and Technology


Rapid Minor Variants Identification in Therapeutic Antibodies by 2D-LC/Q Exactive System

Jin Li, Ph.D., Senior Research Associate, Analytical Development and Quality Control, Genentech, Inc.

High-Throughput Analytics from RoboColumn Purification to Product Quality Screening

Sonia Taktak, Ph.D., Development Scientist III, Analytical and Pharmaceutical Sciences, ImmunoGen, Inc.

Novel Approach towards the Evaluation of Critical Quality Attributes and Stability of Proteins

Belinda Pastrana, Ph.D., Faculty, Chemistry, University of Puerto Rico

For more details on the conference, please contact:
Nandini Kashyap
Conference Director
Phone: 781-972-5406

For media partnership opportunities, please contact:
Kaushik Chaudhuri
Director of Product Marketing
Phone: 781-972-5419

For exhibit & sponsorship opportunities, please contact:

Companies A-K
Sherry Johnson
Business Development Manager
Phone: 781-972-1359

Companies L-Z
Carolyn Benton
Business Development Manager
Phone: 781-972-5412

OutlookYouTubeFacebookLinkedInTwitter #BPSMT

Japan-Flag Korea-Flag China-Simplified-Flag China-Traditional-Flag  

Event at a Glance
Event at a Glance

Celebrating 25 Years


Premier Sponsor

Unchained Labs(1)